tility of Individualized Homoeopathic Medicines in Treatment of Moderate Depression: A Prospective, Intervention Clinical Trial

State National Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1.Cases suffering from depression, diagnosed as per DSM-V criteria [18]
•2.Moderate cases of depression (PHQ9 scores 15 to 19)
•3.Patients must not have been taking antidepressants or anxiolytic drugs at the time of inclusion
•4.Both male and female patients
•5.Age between 18 and 65 years
•6.Capability and willingness to give informed consent and to comply with the study procedures
•7.Patients who can read English and/or Hindi

•1.Severe (PHQ9 <= 19) cases of depression; Â± suicide attempt
•2.Patients with other psychiatric diseases; e. g. schizophrenia or other psychotic disorders, bipolar affective disorder, schizoaffective disorders, alcohol or other substance abuse, eating disorders, psychosis, mania, hypomania or any other Axis I disorder except panic disorder, personality disorders, history of seizures
•3.A clinically significant acute or chronic disease that would hinder regular participation in the study
•4.Treatment with antipsychotics, antidepressants, sedatives/hypnotics or mood stabilizers four weeks prior to the screening
•5.Complementary or alternative treatment used simultaneously to the study (for example acupuncture, phytotherapy, psychotherapy etc.)
•6.Homeopathic treatment for any chronic diseases eight weeks prior to study entry
•7.Cases suffering from uncontrolled systemic illness or life-threatening infections
•8.Self-reported immune-compromised state
•9.Pregnant women and lactating mothers

发起方

State National Homoeopathic Medical College and Hospital